var data={"title":"Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - C4","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - C4</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-c4/contributors\" class=\"contributor contributor_credentials\">Lloyd Axelrod, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-c4/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 03, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">ANSWER</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Incorrect.</p><p>The patient needs more insulin. Assuming conservatively a dose requirement of 0.8 <span class=\"nowrap\">units/kg</span> for an obese patient with type 2 diabetes, the estimated dose requirement is 72 units per 24 hours for this patient. The problem is not the insulin schedule. Having started with a regimen of glargine insulin at bedtime, the next step is to increase the dose. Hypoglycemia is unlikely to occur because of the low frequency of hypoglycemic reactions with bedtime glargine insulin in type 2 diabetes and the low dose of insulin at this time.</p><p>While the approach you have chosen will increase the total dose of insulin, it adds complexity, inconvenience, and cost (for syringes, for example), all of which are associated with decreased patient adherence in patients with diabetes, as in other chronic disorders.</p><p>Return to the previous choice to try again. (See <a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a2\" class=\"medical medical_answer\">&quot;Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A2&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 4099 Version 5.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H1\" id=\"outline-link-H1\">ANSWER</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=interactive-diabetes-case-2-switching-from-oral-agents-to-insulin-in-type-2-diabetes-a2\" class=\"medical medical_answer\">Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes - A2</a></li></ul></div></div>","javascript":null}